A detailed history of Soltis Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Soltis Investment Advisors LLC holds 2,376 shares of AMGN stock, worth $627,264. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,376
Previous 2,024 17.39%
Holding current value
$627,264
Previous $632,000 21.04%
% of portfolio
0.08%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$309.38 - $337.38 $108,901 - $118,757
352 Added 17.39%
2,376 $765,000
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $103,786 - $126,127
-395 Reduced 16.33%
2,024 $632,000
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $4,839 - $5,842
-18 Reduced 0.74%
2,419 $687,000
Q4 2023

Jan 26, 2024

BUY
$255.7 - $288.46 $15,597 - $17,596
61 Added 2.57%
2,437 $701,000
Q3 2023

Nov 08, 2023

BUY
$218.65 - $271.46 $66,032 - $81,980
302 Added 14.56%
2,376 $638,000
Q2 2023

Aug 08, 2023

BUY
$214.27 - $253.37 $172,273 - $203,709
804 Added 63.31%
2,074 $460,000
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $64,124 - $78,156
284 Added 28.8%
1,270 $307,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $6,733 - $7,594
30 Added 3.14%
986 $222,000
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $10,151 - $11,296
44 Added 4.82%
956 $233,000
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $208,306 - $230,441
-950 Reduced 51.02%
912 $221,000
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $370,314 - $423,791
1,862 New
1,862 $419,000
Q3 2021

Nov 09, 2021

SELL
$212.27 - $248.7 $230,525 - $270,088
-1,086 Closed
0 $0
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $619,921 - $687,757
-2,654 Reduced 70.96%
1,086 $265,000
Q1 2021

May 11, 2021

BUY
$221.91 - $258.6 $310,230 - $361,522
1,398 Added 59.69%
3,740 $931,000
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $506,761 - $603,463
2,342 New
2,342 $538,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Soltis Investment Advisors LLC Portfolio

Follow Soltis Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soltis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soltis Investment Advisors LLC with notifications on news.